Is vaginal administration the "way out" of the hormone of controversy?
Menopause
.
2016 Mar;23(3):235.
doi: 10.1097/GME.0000000000000608.
Authors
Andrea R Genazzani
1
,
Nicola Pluchino
Affiliation
1
Division of Gynecology and Obstetrics University of Pisa Pisa, Italy Division of Gynecology and Obstetrics University Hospital of Geneva Geneva, Switzerland and Yale University School of Medicine New Haven, Connecticut.
PMID:
26859345
DOI:
10.1097/GME.0000000000000608
No abstract available
Publication types
Editorial
MeSH terms
Administration, Intravaginal
Administration, Oral
Dehydroepiandrosterone / administration & dosage*
Female
Hormone Replacement Therapy
Humans
Postmenopause / drug effects*
Vagina / drug effects*
Substances
Dehydroepiandrosterone